Literature for IPSI-001 (T01.013 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2016
1. Kuzina,E.S., Kudriaeva,A.A., Maltseva,D.V. and Belogurov AA Jr
   Peptidyl aldehyde specifically interacts with immunosubunit beta1i proteasome: in vitro and in vivo effects
   Bull Exp Biol Med161, 69-71. PubMed  Europe PubMed DOI  I
2014
2. Kisselev,A.F. and Groettrup,M.
   Subunit specific inhibitors of proteasomes and their potential for immunomodulation
   Curr Opin Chem Biol23, 16-22. PubMed  Europe PubMed DOI  I
2011
3. Kuhn,D.J., Orlowski,R.Z. and Bjorklund,C.C.
   Second generation proteasome inhibitors: carfilzomib and immunoproteasome-specific inhibitors (IPSIs)
   Curr Cancer Drug Targets11, 285-295. PubMed  Europe PubMed DOI  I
2009
4. Kuhn,D.J., Hunsucker,S.A., Chen,Q., Voorhees,P.M., Orlowski,M. and Orlowski,R.Z.
   Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors
   Blood113, 4667-4676. PubMed  Europe PubMed DOI  I